Sacubitril And Valsartan Tablet, Film Coated
NDC Package 43598-643-60
Package Information
Sacubitril And Valsartan tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. This formulation utilizes a tablet, film coated delivery system. Marketed by Dr. Reddy's Laboratories Inc., this product is identified by NDC 43598-643 and is authorized under FDA application ANDA213627.
Identification & Billing
- RxCUI: 1656340 - sacubitril 24 MG / valsartan 26 MG Oral Tablet
- RxCUI: 1656349 - sacubitril 49 MG / valsartan 51 MG Oral Tablet
- RxCUI: 1656354 - sacubitril 97 MG / valsartan 103 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 43598 - Dr. Reddy's Laboratories Inc.
- 43598-643 - Sacubitril And Valsartan
- 43598-643-60 - 60 TABLET, FILM COATED in 1 BOTTLE
- 43598-643 - Sacubitril And Valsartan
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (43598-643). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 43598-643-60 identifies a specific commercial package of 60 tablet, film coated in 1 bottle of Sacubitril And Valsartan Sacubitril And Valsartan, a human prescription drug labeled by Dr. Reddy's Laboratories Inc.. This tablet, film coated is formulated for oral use and contains sacubitril; valsartan as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dr. Reddy's Laboratories Inc. on July 16, 2025. The current certification is valid through December 31, 2026.
How is this Dr. Reddy's Laboratories Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 43598064360. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.